Genetic Association of the CCR5 Region With Lipid Levels in At-Risk Cardiovascular Patients

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Circulation: Cardiovascular Genetics

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCGENETICS.109.897793PMID 20130232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of polymorphisms of CC-chemokine receptor-5 gene in acute myocardial infarction and biological implications for longevity

  2008cited by this paper
• Genetic control of chemokines in severe human internal carotid artery stenosis.

  2008cited by this paper
• Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.

  2008cited by this paper
• Common CCR5-del32 Frameshift Mutation Associated With Serum Levels of Inflammatory Markers and Cardiovascular Disease Risk in the Bruneck Population

  2008cited by this paper
• CC chemokine receptor 5 influences late-stage atherosclerosis.

  2007cited by this paper
• Chemokines in vascular remodeling

  2007cited by this paper
• Statins Disrupt CCR5 and RANTES Expression Levels in CD4+ T Lymphocytes In Vitro and Preferentially Decrease Infection of R5 Versus X4 HIV-1

  2007cited by this paper
• Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.

  2007cited by this paper
• The immune response in atherosclerosis: a double-edged sword

  2006cited by this paper
• Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice

  2006cited by this paper
• Role of Bone Marrow–Derived CC-Chemokine Receptor 5 in the Development of Atherosclerosis of Low-Density Lipoprotein Receptor Knockout Mice

  2006cited by this paper
• Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women.

  2006cited by this paper
• Pitavastatin-induced downregulation of CCR2 and CCR5 in monocytes is associated with the arrest of cell-cycle in S phase.

  2006cited by this paper
• AIDS Res Hum Retroviruses

  2006cited by this paper
• Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

  2005cited by this paper
• HIV Entry Inhibitor TAK-779 Attenuates Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice

  2005cited by this paper
• CC chemokine receptor 5 (CCR5) deletion polymorphism does not protect Czech males against early myocardial infarction

  2005cited by this paper
• Chemokine receptor CCR5: insights into structure, function, and regulation.

  2004cited by this paper
• Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice

  2004cited by this paper
• Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study.

  2004cited by this paper
• Chemokines in the pathogenesis of vascular disease.

  2004cited by this paper
• Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis.

  2004cited by this paper
• Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.

  2001cited by this paper
• Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction

  2001cited by this paper
• The CF mouse: an important tool for studying cystic fibrosis

  2001cited by this paper
• Atherosclerosis: role of chemokines and macrophages

  2001cited by this paper
• Intranasal Immunization with HIV Reverse Transcriptase: Effect of Dose in the Induction of Helper T Cell Type 1 and 2 Immunity

  2000cited by this paper
• Global distribution of the CCR5 gene 32-basepair deletion

  1997cited by this paper
• Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32*

  1997cited by this paper
• Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

  1996cited by this paper

• Chemokine receptors in GtoPdb v.2025.3

  2025cites this paper
• Analysis and validation of hub genes for atherosclerosis and AIDS and immune infiltration characteristics based on bioinformatics and machine learning

  2025cites this paper
• Chemokine receptors in GtoPdb v.2025.1

  2025cites this paper
• Chemokine receptors in GtoPdb v.2023.1 Chemokine receptors in GtoPdb v.2023.1

  2023cites this paper
• Investigation of the Correlation Between the Polymorphism/Expression Level of RANTES and Its Receptor CCR5 Gene Promoter and Type 2 Diabetes Mellitus

  2023cites this paper
• Targeting the chemokine network in atherosclerosis.

  2021cites this paper
• Chemokine Receptor 5, a Double-Edged Sword in Metabolic Syndrome and Cardiovascular Disease

  2020cites this paper
• Metabolomics as an Approach to Characterise the Contrasting Roles of CCR5 in the Presence and Absence of Disease

  2020influential citation
• New mechanisms of CCR5-Δ32 carriers' advantage - Impact on progenitor cells and renal function.

  2019cites this paper
• Designer nucleases: Gene-editing therapies using CCR5 as an emerging target in HIV.

  2019cites this paper
• Chemokine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• CCR5‐&Dgr;32 polymorphism is a genetic risk factor associated with dyslipidemia in patients with type 1 diabetes

  2019cites this paper
• Data integration for functional annotation of regulatory single nucleotide polymorphisms associated with Alzheimer's disease susceptibility.

  2018cites this paper
• CCL5-CCR5 Interactions in Breast Cancer Regulate Cell Metabolism

  2017cites this paper
• Maraviroc Reduces Arterial Stiffness in PI-Treated HIV-infected Patients

  2016cites this paper
• Relationship of Genetic Polymorphisms of the Chemokine, CCL5, and Its Receptor, CCR5, with Coronary Artery Disease in Taiwan

  2015cites this paper
• The impact of CCR5-Δ32 deletion on C-reactive protein levels and cardiovascular disease: Results from the Danish Blood Donor Study.

  2015cites this paper
• Synthesis, binding affinity and structure-activity relationships of novel, selective and dual targeting CCR2 and CCR5 receptor antagonists.

  2015cites this paper
• CCR5Δ32 POLYMORPHISM NOT DETECTED IN HIV PATIENTS IN VOLUNTARY COUNSELING AND TESTING MOEWARDI GENERAL HOSPITAL SURAKARTA, INDONESIA

  2015cites this paper
• Diverse modifications of the 4-methylphenyl moiety of TAK-779 by late-stage Suzuki-Miyaura cross-coupling.

  2014cites this paper
• Evidence of a Polygenic Origin of Extreme High-Density Lipoprotein Cholesterol Levels

  2013cites this paper
• Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low‐dose atorvastatin treatment: evidence from a randomized controlled trial

  2013cites this paper
• CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users

  2013cites this paper
• C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection☆

  2013cites this paper
• General Cardiovascular Risk Profile Identifies Advanced Coronary Artery Calcium and Is Improved by Family History: The Multiethnic Study of Atherosclerosis

  2012cites this paper
• Bedeutung von Chemokinen in der Atherogenese

  2011cites this paper
• Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial

  2011cites this paper
• Chemokine receptor CCR5: from AIDS to atherosclerosis

  2011cites this paper
• Comparative Lipidomics Profiling of Human Atherosclerotic Plaques

  2011cites this paper